Association between anti‐endothelial antigen antibodies and allograft rejection in kidney transplantation
Journal of Clinical Laboratory Analysis · 2023
DOI: 10.1002/jcla.24961 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2023. Verfasst von Hyun Ji Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Pusan National University School of Medicine, Yangsan, Korea. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Research Institute for Convergence Biomedical Science and Technology, Pusan National University Yangsan Hospital.
Abstract (Originalsprache)
Background
Endothelial cells are vital in the transplant immune system as semiprofessional antigen‐presenting cells. Few studies have investigated the importance of anti‐endothelin subtype A receptor (ETAR) antibodies in kidney transplantation. Here, we aimed to analyze the association between anti‐angiotensin II type I receptor (AT1R) and anti‐ETAR antibodies and the association between the presence of anti‐endothelial antibodies and the risk of allograft rejection in kidney transplantation.
Methods
In total, 252 patients who underwent kidney transplantation were enrolled in this study. Antibodies for human leukocyte antigens (HLAs) and non‐HLAs were analyzed immediately before transplantation. Patients were categorized based on the occurrence of antibody‐mediated rejection (AMR) or T‐cell‐mediated rejection (TCMR) by 2017 Banff classification. All p ‐values were two‐tailed, and statistical significance was set at p < 0.05.
Results
Patients with anti‐AT1R antibodies had a 3.49‐fold higher risk of TCMR than those without anti‐AT1R antibodies. Patients with anti‐ETAR antibodies had a 5.84‐fold higher risk of AMR than those without anti‐ETAR antibodies. The hazard ratio of AMR in patients with both HLA DSAs and anti‐ETAR antibodies, relative to patients without anti‐ETAR antibodies and HLA DSAs, was 32.85 (95% CI = 1.82–592.91).
Conclusion
Our findings indicated that anti‐ETAR antibodies are associated with AMR, and patients with both anti‐ETAR antibodies and de novo HLA DSAs were at a high risk of AMR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Pusan National University School of Medicine, Yangsan, Korea.
- Transplant Research Center, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea.
- Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Korea.
- Department of Surgery, Pusan National University School of Medicine, Yangsan, Korea.
- BioMedical Informatics Unit, Pusan National University School of Medicine, Busan, Korea.
ORCID-Profile: Hyun Ji Lee
Förderung
- Research Institute for Convergence Biomedical Science and Technology, Pusan National University Yangsan Hospital
Zitieren
APA
Lee, H. J., Shin, K. H., Kim, I. Y., Choi, B. H., & Kim, H. H. (2023). Association between anti‐endothelial antigen antibodies and allograft rejection in kidney transplantation. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.24961
Vancouver
Lee HJ, Shin KH, Kim IY, Choi BH, Kim HH. Association between anti‐endothelial antigen antibodies and allograft rejection in kidney transplantation. Journal of Clinical Laboratory Analysis. 2023. doi:10.1002/jcla.24961
BibTeX
@article{Lee2023,
author = {Lee, Hyun Ji and Shin, Kyung-Hwa and Kim, Il Young and Choi, Byung Hyun and Kim, Hyung-Hoi},
title = {Association between anti‐endothelial antigen antibodies and allograft rejection in kidney transplantation},
journal = {Journal of Clinical Laboratory Analysis},
year = {2023},
doi = {10.1002/jcla.24961}
}
EUVIMED